Hannah M. Yamagata

California University of Pennsylvania

Papers

1

Total Citations

3

H-Index

1

About

Hannah M. Yamagata is pioneering the high-throughput engineering of lipid nanoparticles (LNPs) for next-generation therapeutics. Her research sits at the intersection of microfluidics, nanomedicine, and combinatorial chemistry, with a primary focus on automating the design and synthesis of precisely defined LNP libraries. In her landmark 2025 paper, "Automated and Parallelized Microfluidic Generation of Large and Precisely Defined Lipid Nanoparticle Libraries," Yamagata introduced a platform that enables the rapid, parallelized formulation of LNPs by systematically varying both lipid structure and stoichiometry. This work directly addresses a critical bottleneck in nanomedicine: the slow, manual optimization of LNP compositions for drug delivery. By enabling the generation of hundreds of well-defined formulations in a single run, her approach dramatically accelerates the discovery of potent LNPs for mRNA vaccines, gene editing, and cancer therapies. Though early in her career, her contributions are already garnering attention (3 citations for her key paper), signaling a rising impact. Yamagata’s work promises to transform how researchers screen and optimize lipid-based carriers, making personalized nanotherapies more accessible and efficient.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Automated and Parallelized Microfluidic Generation of Large and Precisely Defined Lipid Nanoparticle Libraries
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: California University of Pennsylvania

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago